Faster answers at the bedside.
A point-of-care diagnostic for methotrexate measurement — results in under 10 minutes, no lab required.
Learn More Learn MoreOvercoming the challenges of MTX measurement
Currently, blood analysis of methotrexate for high-dose oncology therapy requires immunoassays in hospital labs with specialized equipment and trained technicians — adding cost, time, and complexity. We're developing a low-cost, simple-to-use diagnostic in the point-of-care format.
See the Product See the ProductHow it works
Collect 40 µl whole blood
Using a fixed volume pipet, collect a small whole blood sample — no centrifuge or special preparation needed.
Apply to the lateral flow device
Add the sample and buffer to the lateral flow device. The double antibody system begins detecting methotrexate immediately.
Read quantitative results in ≤ 10 minutes
Place the off-the-shelf digital reader onto the device. Remove and record results — all at the bedside.
No cross-reactivity
Unlike competitors with 20–100% DAMPA cross-reactivity, our double antibody system measures methotrexate only.
Results in ≤ 10 minutes
Bedside results without the 1.5–2 hour wait of traditional immunoassays. Faster answers when they matter most.
Simple enough for any healthcare professional
No specialized technician required. Five steps, no centrifuge, no serial dilution — just collect, apply, and read.
Interested in partnering?
We're looking for clinical collaborators, distribution partners, and investors.
Contact Us →